{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diabetic+Neuropathy%2C+Painful&page=3", "query": { "condition": "Diabetic Neuropathy, Painful", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 152, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diabetic+Neuropathy%2C+Painful&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Diabetic+Neuropathy%2C+Painful&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-08T23:30:23.155Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05754190", "title": "Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Pain", "Acute Pain", "Post Operative Pain", "Fibromyalgia, Primary", "Fibromyalgia, Secondary", "Fibromyalgia", "Irritable Bowel Syndrome", "Chronic Headache Disorder", "Chronic Migraine", "Chronic Pelvic Pain Syndrome", "Temporomandibular Joint Disorders", "Endometriosis-related Pain", "Arthritis", "Chronic Low-back Pain", "Failed Back Surgery Syndrome", "Post Herpetic Neuralgia", "Neuropathic Pain", "Painful Diabetic Neuropathy", "Painful Bladder Syndrome", "Trauma-related Wound", "Trauma, Multiple", "Chronic Pain Syndrome", "Chronic Shoulder Pain" ], "interventions": [ { "name": "SOMA pain manager smartphone application", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Brown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 800, "start_date": "2023-06-20", "completion_date": "2026-05-30", "has_results": false, "last_update_posted_date": "2025-09-19", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT05754190" }, { "nct_id": "NCT00904202", "title": "A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Postherpetic Neuralgia", "Diabetic Neuropathy", "Complex Regional Pain Syndrome", "Carpal Tunnel Syndrome", "HIV Neuropathy", "Idiopathic Sensory Neuropathy", "Peripheral Neuropathy" ], "interventions": [ { "name": "Placebo Capsules + Placebo Patch", "type": "DRUG" }, { "name": "Placebo capsules + Lidoderm®", "type": "DRUG" }, { "name": "Gabapentin + Placebo", "type": "DRUG" }, { "name": "Gabapentin + Lidoderm®", "type": "DRUG" }, { "name": "Gabapentin 300 mg capsules 1800 mg/day + placebo patch", "type": "DRUG" }, { "name": "Gabapentin 1800 mg/day + Lidoderm patch", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endo USA Inc., a Keenova Therapeutics Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 62, "start_date": "2003-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2024-01-02", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 7, "location_summary": "Birmingham, Alabama • Hueytown, Alabama • Phoenix, Arizona + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Hueytown", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Pembroke Pines", "state": "Florida" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00904202" }, { "nct_id": "NCT01939366", "title": "Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Pain", "Diabetic Neuropathies", "Diabetes Mellitus" ], "interventions": [ { "name": "Cebranopadol 100 µg", "type": "DRUG" }, { "name": "Cebranopadol 300 µg", "type": "DRUG" }, { "name": "Cebranopadol 600 µg", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tris Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 699, "start_date": "2013-09-27", "completion_date": "2015-01-28", "has_results": true, "last_update_posted_date": "2021-07-15", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 15, "location_summary": "Mesa, Arizona • Garden Grove, California • Laguna Hills, California + 11 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Garden Grove", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01939366" }, { "nct_id": "NCT02842554", "title": "Training \"Pain Connoisseurs\" for Efficient Analgesic Proof-of-Concept Studies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Painful Diabetic Neuropathy (PDN)" ], "interventions": [ { "name": "EPT", "type": "OTHER" }, { "name": "Drug Placebo Administration", "type": "DRUG" }, { "name": "C", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Analgesic Solutions", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 98, "start_date": "2013-08", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2016-07-25", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 1, "location_summary": "Natick, Massachusetts", "locations": [ { "city": "Natick", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02842554" }, { "nct_id": "NCT01288937", "title": "A Placebo Controlled, Randomized, Double Blind Trial of Milnacipran for the Treatment of Idiopathic Neuropathy Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Idiopathic Peripheral Neuropathy" ], "interventions": [ { "name": "Milnacipran", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 6, "start_date": "2011-04-05", "completion_date": "2014-12-23", "has_results": true, "last_update_posted_date": "2020-09-03", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01288937" }, { "nct_id": "NCT00553592", "title": "Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Peripheral Neuropathy" ], "interventions": [ { "name": "Bicifadine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "XTL Biopharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 336, "start_date": "2007-09", "completion_date": "2008-12", "has_results": false, "last_update_posted_date": "2007-11-05", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 1, "location_summary": "Paducah, Kentucky", "locations": [ { "city": "Paducah", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00553592" }, { "nct_id": "NCT01822925", "title": "Study of DA-9801 to Treat Diabetic Neuropathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Neuropathy" ], "interventions": [ { "name": "DA-9801 300mg", "type": "DRUG" }, { "name": "DA-9801 600mg", "type": "DRUG" }, { "name": "DA-9801 900mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NeuroBo Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 128, "start_date": "2013-11", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2020-03-20", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 14, "location_summary": "Lakewood, California • Walnut Creek, California • Milford, Connecticut + 10 more", "locations": [ { "city": "Lakewood", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Milford", "state": "Connecticut" }, { "city": "Brandon", "state": "Florida" }, { "city": "West Palm Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01822925" }, { "nct_id": "NCT00134524", "title": "The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Neuropathies", "Pain", "Neuralgia" ], "interventions": [ { "name": "MME procedure", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Advanced Magnetic Research Institute International", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 100, "start_date": "2005-07", "completion_date": "2008-01", "has_results": false, "last_update_posted_date": "2007-07-10", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 5, "location_summary": "Tucson, Arizona • Sterling Heights, Michigan • Mocksville, North Carolina + 2 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Sterling Heights", "state": "Michigan" }, { "city": "Mocksville", "state": "North Carolina" }, { "city": "Toledo", "state": "Ohio" }, { "city": "Renton", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00134524" }, { "nct_id": "NCT00643760", "title": "A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neuropathy, Diabetic" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "GEn 1200mg/day", "type": "DRUG" }, { "name": "GEn 2400mg/day", "type": "DRUG" }, { "name": "GEn 3600mg/day", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "XenoPort, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 421, "start_date": "2008-03", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2013-07-22", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 90, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Dothan, Alabama + 81 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00643760" }, { "nct_id": "NCT04687215", "title": "Diabetic Neuropathy in Spinal Cord Stimulator Patients", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diabetes Mellitus", "Neuropathy", "Neuropathic Pain", "Vascular Diseases", "Vascular Stiffness", "Microvascular Changes", "Pain, Chronic" ], "interventions": [], "intervention_types": [], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2022-01-27", "completion_date": "2026-12-01", "has_results": false, "last_update_posted_date": "2026-02-05", "last_synced_at": "2026-10-08T23:30:23.155Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04687215" } ] }